Dark Forest Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Dark Forest Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,225	Closed	-$1.01M	–	1200
2025 Q1	$1.01M	Buy	+14,225	New	+$957K	0.05%	687
2024 Q4	–	Sell	-5,663	Closed	-$398K	–	960
2024 Q3	$398K	Buy	+5,663	New	+$473K	0.05%	484
2023 Q4	–	Sell	-17,388	Closed	-$1.54M	–	533
2023 Q3	$1.54M	Buy	17,388 +9,108	+110%	+$810K	0.12%	238
2023 Q2	$718K	Buy	8,280 +7,901	+2,085%	+$744K	0.07%	455
2023 Q1	$36.9K	Buy	+379	New	+$39.3K	0.01%	890
2022 Q4	–	Sell	-708	Closed	-$60K	–	1165
2022 Q3	$60K	Buy	+708	New	+$63K	0.01%	504
2021 Q4	–	Sell	-90	Closed	-$7K	–	1445
2021 Q3	$7K	Buy	+90	New	+$7.1K	﹤0.01%	1037

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dark Forest Capital Management's BMRN Position: Q2 2025 in Review

Dark Forest Capital Management sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2025, closing a stake of 14,225 shares — an estimated $1.01M sold.

Dark Forest Capital Management first reported a position in BMRN in Q3 2021 and held it in 7 quarters. The position peaked at $1.54M in Q3 2023. 581 funds tracked by Wall St. Rank hold BMRN as of Q2 2025.

Dark Forest Capital Management reported no remaining BioMarin Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Dark Forest Capital Management sold 14,225 BioMarin Pharmaceuticals shares in Q2 2025, an estimated $1.01M.
Dark Forest Capital Management first reported a position in BioMarin Pharmaceuticals in Q3 2021 and held it in 7 quarters.
Dark Forest Capital Management's BioMarin Pharmaceuticals position peaked at $1.54M in Q3 2023.
581 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2025.

Based on Dark Forest Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.